How can we improve the outcome for transplant patients with nontuberculous mycobacterial infections?

Shweta Anjan, Michele I. Morris

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Nontuberculous mycobacteria (NTM) are environmental organisms that are rapidly emerging as pathogens in the transplant population. The prevalence of infection in transplant recipients remains unknown. While guidelines exist for treatment of NTM, neither the American Thoracic Society, the Infectious Diseases Society of America, nor the British Thoracic Society guidelines dictate the approach needed for transplant recipients. Here, we summarize risk factors, important diagnostic and treatment facts, and preventive measures to be taken to help improve outcomes of those infected with NTM infections.

Original languageEnglish (US)
Pages (from-to)903-914
Number of pages12
JournalFuture Microbiology
Volume13
Issue number8
DOIs
StatePublished - 2018

Keywords

  • M. abscessus
  • M. avium complex
  • clinical monitoring
  • drug interactions
  • hematopoietic cell transplant
  • mycobacteria
  • nontuberculous
  • pretransplant risk
  • prevention
  • solid organ transplant

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Fingerprint Dive into the research topics of 'How can we improve the outcome for transplant patients with nontuberculous mycobacterial infections?'. Together they form a unique fingerprint.

Cite this